Atomistic modeling towards predictive cardiotoxicity
暂无分享,去创建一个
Kevin R. DeMarco | John R.D. Dawson | Slava Bekker | Vladimir Yarov-Yarovoy | Colleen E. Clancy | Igor Vorobyov | Pei Chi Yang | Van Ngo | Sergei Y. Noskov | V. Yarov-Yarovoy | I. Vorobyov | S. Noskov | C. Clancy | Pei-Chi Yang | K. DeMarco | Van A. Ngo | Slava Bekker | John R. D. Dawson | V. Ngo
[1] D. Baker,et al. Multipass membrane protein structure prediction using Rosetta , 2005, Proteins.
[2] Jianlin Lei,et al. Structure of the Nav1.4-β1 Complex from Electric Eel , 2017, Cell.
[3] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[4] S Durdagi,et al. Insights into the molecular mechanism of hERG1 channel activation and blockade by drugs. , 2010, Current medicinal chemistry.
[5] Thomas V. McDonald,et al. S641 contributes HERG K+ channel inactivation , 2007, Cell Biochemistry and Biophysics.
[6] J. Ruskin,et al. The cardiac arrhythmia suppression trial (CAST). , 1989, The New England journal of medicine.
[7] KumarShankar,et al. The weighted histogram analysis method for free-energy calculations on biomolecules. I , 1992 .
[8] A. Szabó,et al. Role of diffusion in ligand binding to macromolecules and cell-bound receptors. , 1982, Biophysical journal.
[9] T. Colatsky,et al. The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative - Update on progress. , 2016, Journal of pharmacological and toxicological methods.
[10] Colleen E. Clancy,et al. In silico prediction of drug therapy in catecholaminergic polymorphic ventricular tachycardia , 2015, The Journal of physiology.
[11] R. Kass,et al. Common Molecular Determinants of Flecainide and Lidocaine Block of Heart Na+ Channels , 2003, The Journal of general physiology.
[12] David Baker,et al. Prediction of the structure of symmetrical protein assemblies , 2007, Proceedings of the National Academy of Sciences.
[13] T. Colatsky,et al. A New Perspective in the Field of Cardiac Safety Testing through the Comprehensive In Vitro Proarrhythmia Assay Paradigm , 2016, Journal of biomolecular screening.
[14] Henry J. Duff,et al. The Pore-Lipid Interface: Role of Amino-Acid Determinants of Lipophilic Access by Ivabradine to the hERG1 Pore Domain , 2019, Molecular Pharmacology.
[15] M. Sanguinetti,et al. Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide. , 1993, Circulation research.
[16] G. Torrie,et al. Nonphysical sampling distributions in Monte Carlo free-energy estimation: Umbrella sampling , 1977 .
[17] Colleen E. Clancy,et al. Channel Openings Are Necessary but not Sufficient for Use-dependent Block of Cardiac Na+ Channels by Flecainide , 2002, The Journal of general physiology.
[18] Serdar Durdagi,et al. Modeling of Open, Closed, and Open-Inactivated States of the hERG1 Channel: Structural Mechanisms of the State-Dependent Drug Binding , 2012, J. Chem. Inf. Model..
[19] Manuchair Ebadi. Desk Reference of Clinical Pharmacology , 2007 .
[20] Xiao Zhu,et al. Recent developments and applications of the CHARMM force fields , 2012, Wiley interdisciplinary reviews. Computational molecular science.
[21] M Gwilt,et al. Selective class III antiarrhythmic agents. 1 Bis(arylalkyl)amines. , 1990, Journal of medicinal chemistry.
[22] J. Aronson,et al. Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature , 2016, BMC Medicine.
[23] D A Smith,et al. Pharmacokinetics of a series of bis(methanesulphonamido-arylalkyl)amines in the beagle dog. , 1996, Xenobiotica; the fate of foreign compounds in biological systems.
[24] Colleen E. Clancy,et al. Multiscale Modeling in the Clinic: Drug Design and Development , 2016, Annals of Biomedical Engineering.
[25] Klaus Schulten,et al. Rapid parameterization of small molecules using the force field toolkit , 2013, J. Comput. Chem..
[26] Laxmikant V. Kalé,et al. Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..
[27] Roderick MacKinnon,et al. Cryo-EM Structure of the Open Human Ether-à-go-go-Related K+ Channel hERG , 2017, Cell.
[28] Michael C Sanguinetti,et al. Predicting drug-hERG channel interactions that cause acquired long QT syndrome. , 2005, Trends in pharmacological sciences.
[29] Jacob J. Schmidt,et al. Single channel and ensemble hERG conductance measured in droplet bilayers , 2015, Biomedical microdevices.
[30] A. IJzerman,et al. K v 11.1 (hERG)-induced cardiotoxicity: a molecular insight from a binding kinetics study of prototypic K v 11.1 inhibitors , 2015 .
[31] Kresten Lindorff-Larsen,et al. Principles of conduction and hydrophobic gating in K+ channels , 2010, Proceedings of the National Academy of Sciences.
[32] Amir Lerman,et al. Drug attrition during pre-clinical and clinical development: understanding and managing drug-induced cardiotoxicity. , 2013, Pharmacology & therapeutics.
[33] Ron O. Dror,et al. Mechanism of Voltage Gating in Potassium Channels , 2012, Science.
[34] Kevin R. DeMarco,et al. A computational pipeline to predict cardiotoxicity: From the atom to the rhythm , 2019, bioRxiv.
[35] Toby W Allen,et al. Estimation of Potentials of Mean Force from Nonequilibrium Pulling Simulations Using Both Minh-Adib Estimator and Weighted Histogram Analysis Method. , 2016, Journal of chemical theory and computation.
[36] Klaus Schulten,et al. GPU-accelerated molecular modeling coming of age. , 2010, Journal of molecular graphics & modelling.
[37] G A Gutman,et al. Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. , 1994, Molecular pharmacology.
[38] Kara L Lynch,et al. Role of liquid chromatography–high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology , 2012, Clinical toxicology.
[39] J Brown,et al. Molecular Determinants of Voltage-dependent Gating and Binding of Pore-blocking Drugs in Transmembrane Segment IIIS6 of the Na+ Channel α Subunit* , 2001, The Journal of Biological Chemistry.
[40] G. Robertson,et al. Transfer of rapid inactivation and sensitivity to the class III antiarrhythmic drug E‐4031 from HERG to M‐eag channels , 1998, The Journal of physiology.
[41] M. Sanguinetti,et al. Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides. , 1996, Circulation research.
[42] Michael P. Eastwood,et al. Atomic-level simulation of current–voltage relationships in single-file ion channels , 2013, The Journal of general physiology.
[43] Jamie I Vandenberg,et al. Drug Binding to the Inactivated State Is Necessary but Not Sufficient for High-Affinity Binding to Human Ether-à-go-go-Related Gene Channels , 2008, Molecular Pharmacology.
[44] Kevin R. DeMarco,et al. A multiscale computational modelling approach predicts mechanisms of female sex risk in the setting of arousal‐induced arrhythmias , 2017, The Journal of physiology.
[45] B. Hille,et al. Local anesthetics: hydrophilic and hydrophobic pathways for the drug- receptor reaction , 1977, The Journal of general physiology.
[46] Catherine Vénien-Bryan,et al. Cryo-electron microscopy and X-ray crystallography: complementary approaches to structural biology and drug discovery. , 2017, Acta crystallographica. Section F, Structural biology communications.
[47] Williams E. Miranda,et al. Computational membrane biophysics: From ion channel interactions with drugs to cellular function. , 2017, Biochimica et biophysica acta. Proteins and proteomics.
[48] M. Sanguinetti,et al. hERG potassium channels and cardiac arrhythmia , 2006, Nature.
[49] Stefan A. Mann,et al. hERG K(+) channels: structure, function, and clinical significance. , 2012, Physiological reviews.
[50] H. Wellens,et al. Azimilide and dofetilide produce similar electrophysiological and proarrhythmic effects in a canine model of Torsade de Pointes arrhythmias. , 2001, European journal of pharmacology.
[51] J. P. Grossman,et al. Biomolecular simulation: a computational microscope for molecular biology. , 2012, Annual review of biophysics.
[52] B. Roux,et al. The Hidden Energetics of Ligand-Binding and Activation in a Glutamate Receptor , 2010, Nature Structural &Molecular Biology.
[53] Ilkka Ojanperä,et al. Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control , 2012, Analytical and Bioanalytical Chemistry.
[54] Stanley Nattel,et al. Dofetilide block involves interactions with open and inactivated states of HERG channels , 2002, Pflügers Archiv - European Journal of Physiology.
[55] A. Stary-Weinzinger,et al. New potential binding determinant for hERG channel inhibitors , 2016, Scientific Reports.
[56] H. Duff,et al. Molecular determinant of high-affinity dofetilide binding to HERG1 expressed in Xenopus oocytes: involvement of S6 sites. , 2000, Molecular pharmacology.
[57] Toby W Allen,et al. Ion-induced defect permeation of lipid membranes. , 2014, Biophysical journal.
[58] Roy J Vaz,et al. Molecular determinants of loperamide and N-desmethyl loperamide binding in the hERG cardiac K+ channel. , 2017, Bioorganic & medicinal chemistry letters.
[59] E. Behr,et al. Drug-induced arrhythmia: pharmacogenomic prescribing? , 2013, European heart journal.
[60] Anna Tsantili-Kakoulidou,et al. Alternative measures of lipophilicity: from octanol-water partitioning to IAM retention. , 2008, Journal of pharmaceutical sciences.
[61] A M Davis,et al. Robust assessment of statistical significance in the use of unbound/intrinsic pharmacokinetic parameters in quantitative structure-pharmacokinetic relationships with lipophilicity. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[62] W. Catterall,et al. Molecular determinants of state-dependent block of Na+ channels by local anesthetics. , 1994, Science.
[63] F. Ponti,et al. QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience , 2000, European Journal of Clinical Pharmacology.
[64] Vladimir Yarov-Yarovoy,et al. Role of Amino Acid Residues in Transmembrane Segments IS6 and IIS6 of the Na+ Channel α Subunit in Voltage-dependent Gating and Drug Block* , 2002, The Journal of Biological Chemistry.
[65] Alexander D. MacKerell,et al. Automation of the CHARMM General Force Field (CGenFF) I: Bond Perception and Atom Typing , 2012, J. Chem. Inf. Model..
[66] Taehoon Kim,et al. CHARMM‐GUI: A web‐based graphical user interface for CHARMM , 2008, J. Comput. Chem..
[67] T. Kenakin. Principles: receptor theory in pharmacology. , 2004, Trends in pharmacological sciences.
[68] R. MacKinnon,et al. Conduction properties of the cloned Shaker K+ channel. , 1993, Biophysical journal.
[69] Bertram Pitt,et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction , 1996, The Lancet.
[70] Kevin R. DeMarco,et al. A demonstration of modularity, reuse, reproducibility, portability and scalability for modeling and simulation of cardiac electrophysiology using Kepler Workflows , 2019, PLoS Comput. Biol..
[71] Jun Chen,et al. A structural basis for drug-induced long QT syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[72] M K Pugsley,et al. Principles of Safety Pharmacology , 2008, Handbook of Experimental Pharmacology.
[73] R. Swendsen,et al. THE weighted histogram analysis method for free‐energy calculations on biomolecules. I. The method , 1992 .
[74] D. Baker,et al. Toward high-resolution prediction and design of transmembrane helical protein structures , 2007, Proceedings of the National Academy of Sciences.
[75] Yigong Shi. A Glimpse of Structural Biology through X-Ray Crystallography , 2014, Cell.
[76] E. Campbell,et al. Atomic structure of a voltage-dependent K+ channel in a lipid membrane-like environment , 2007, Nature.
[77] Alexander D. MacKerell,et al. Automation of the CHARMM General Force Field (CGenFF) II: Assignment of Bonded Parameters and Partial Atomic Charges , 2012, J. Chem. Inf. Model..
[78] W. Catterall,et al. THE CRYSTAL STRUCTURE OF A VOLTAGE-GATED SODIUM CHANNEL , 2011, Nature.
[79] A. Brown,et al. Molecular determinants of dofetilide block of HERG K+ channels. , 1998, Circulation research.
[80] Kevin R. DeMarco,et al. Digging into Lipid Membrane Permeation for Cardiac Ion Channel Blocker d-Sotalol with All-Atom Simulations , 2018, Front. Pharmacol..
[81] Serdar Durdagi,et al. Role of the pH in state-dependent blockade of hERG currents , 2016, Scientific Reports.
[82] P. Debye,et al. Reaction Rates in Ionic Solutions , 1942 .
[83] D. Kern,et al. Dynamic personalities of proteins , 2007, Nature.
[84] G Duker,et al. Comparison of the IKr blockers moxifloxacin, dofetilide and E‐4031 in five screening models of pro‐arrhythmia reveals lack of specificity of isolated cardiomyocytes , 2012, British journal of pharmacology.
[85] Kevin R. DeMarco,et al. Structural basis for antiarrhythmic drug interactions with the human cardiac sodium channel , 2019, Proceedings of the National Academy of Sciences.
[86] Bernard Testa,et al. Immobilized artificial membrane HPLC in drug research. , 2003, Journal of medicinal chemistry.
[87] H J Duff,et al. Identification and characteristics of delayed rectifier K+ current in fetal mouse ventricular myocytes. , 1996, The American journal of physiology.
[88] Kevin R. DeMarco,et al. Challenges and advances in atomistic simulations of potassium and sodium ion channel gating and permeation , 2018, The Journal of physiology.
[89] J. P. Grossman,et al. Anton 2: Raising the Bar for Performance and Programmability in a Special-Purpose Molecular Dynamics Supercomputer , 2014, SC14: International Conference for High Performance Computing, Networking, Storage and Analysis.
[90] Federico Forneris,et al. Identifying and Visualizing Macromolecular Flexibility in Structural Biology , 2016, Front. Mol. Biosci..
[91] Toby W Allen,et al. Local anesthetic and antiepileptic drug access and binding to a bacterial voltage-gated sodium channel , 2014, Proceedings of the National Academy of Sciences.